Overview
Valued at ~$9.4 billion in 2023, the electrosurgical devices market is projected to reach
~$13.4 billion by 2028, increasing at a CAGR of 7.5% over the 2023-2028
forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for
global medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking, curated
insights, and more.
Electrosurgical devices use a high-frequency electrical current to cauterize, coagulate, and cut tissue during
surgical procedures.
Products included within the scope of this analysis include:
Electrosurgical generators and consumables, including robotic electrosurgical instruments
This Market Snapshot is intended to provide a high-level overview of the global market for electrosurgical
devices, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Electrosurgical Devices Market Snapshot Summary
|
Snapshot Aspect
|
Data and Details
|
|
Base Year for Estimate
|
2023
|
|
Forecast Period
|
2023 - 2028
|
|
Market Size in 2023
|
$9.4 billion
|
|
CAGR
|
7.5%
|
|
Projected Market Size in 2028
|
$13.4 billion
|
Electrosurgical Devices Market Insights
The electrosurgical devices market is seeing steady growth, largely driven by
advancements
in robotic surgery systems and an expanding range of applications for electrosurgery. Robotic surgery,
now seeing steady adoption across soft and hard tissue applications, is significantly influencing the
electrosurgical landscape, with companies like Medtronic, Johnson & Johnson, and Intuitive Surgical leading the
charge.
Worldwide procedure volume for the Intuitive Surgical da VinciⓇ system increased by 21.9% in 2023 versus 2022,
following an increase of 17.6% from 2020 to 2021, representing substantial growth in comparison to the overall
electrosurgical device market.
Consumables are a major source of revenue for companies that commercialize robotic surgical systems. Robotic
surgery devices—such as electrosurgical forceps compatible with surgical robots—are priced substantially higher
than conventional electrosurgical forceps (~10-fold), resulting in an above-average increase in unit pricing and
driving robust growth in the dollar volume market.
Another important trend is the expansion of electrosurgery into a broader range of general surgeries, including
cholecystectomy, appendectomy, and bariatric surgery. As robotic surgery systems become more advanced, they are
being utilized in a broader range of these high-volume procedures.
Looking ahead, Intuitive Surgical is on track to potentially surpass current market leaders Johnson & Johnson
and Medtronic—especially if these competitors cannot effectively penetrate the soft tissue surgical robotics
market. With the approval of another Intuitive system, Intuitive Surgical may secure its position as the
electrosurgical devices market leader in the coming years.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the electrosurgical devices
market. This includes estimated market revenue and market share for key players, such as Intuitive Surgical,
Ethicon/J&J, and Medtronic.
Select Market Events
|
Company
|
Date
|
Event Type
|
Event
|
|
|
3/2024
|
Regulatory
|
Intuitive Surgical announced FDA clearance of its Da Vinci 5™.
|
|
|
10/2024
|
Regulatory
|
Johnson & Johnson submitted its Ottava™ soft tissue surgical robot platform for an FDA IDE
application.
|
Key Companies Covered
Boston Scientific
ConMed
Cooper Surgical
Ethicon
Erbe
Hologic
Intuitive Surgical
Johnson & Johnson
Karl Storz
Medtronic
Minerva Surgical
Olympus
Stryker
